Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS. Tavallai M, Booth L, Roberts JL, McGuire WP, Poklepovic A, Dent P Oncotarget. 2016 Mar 12. PMID: 26981780. Abstract CommentRecommendBookmarkWatch